Couchbase (BASE) Financials

$17.88 -0.30 (-1.67%)

As of 02:38 PM Eastern

Annual Income Statements for Couchbase

This table shows Couchbase's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2025	2024	2023	2022	2021	2020
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020
Net Income / (Loss) Attributable to Common Shareholders	-75	-80	-68	-61	-44	-29
Consolidated Net Income / (Loss)	-75	-80	-68	-58	-40	-29
Net Income / (Loss) Continuing Operations	-75	-80	-68	-58	-40	-29
Total Pre-Tax Income	-73	-79	-67	-57	-39	-28
Total Operating Income	-79	-85	-69	-56	-33	-30
Total Gross Profit	185	158	135	109	92	75
Total Revenue	209	180	155	124	103	83
Operating Revenue	209	180	155	124	103	83
Total Cost of Revenue	25	22	20	15	12	7.80
Operating Cost of Revenue	25	22	20	15	12	7.80
Total Operating Expenses	263	242	204	165	125	105
Selling, General & Admin Expense	51	43	33	24	16	16
Marketing Expense	142	131	111	89	70	58
Research & Development Expense	71	64	58	52	39	32
Impairment Charge	0.00	5.16	0.00	0.00	-	-
Restructuring Charge	0.00	0.05	1.66	0.00	0.00	-
Total Other Income / (Expense), net	5.80	5.71	1.86	-0.96	-5.86	1.85
Interest Expense	0.06	0.04	0.10	0.66	6.97	4.66
Other Income / (Expense), net	5.86	5.75	1.96	-0.30	1.11	6.51
Income Tax Expense	1.80	1.36	1.04	1.02	1.04	0.77
Basic Earnings per Share	($1.45)	($1.70)	($1.53)	($2.37)	($7.71)	($5.33)
Weighted Average Basic Shares Outstanding	51.31M	47.18M	44.79M	25.78M	5.72M	5.49M
Diluted Earnings per Share	($1.45)	($1.70)	($1.53)	($2.37)	($7.71)	($5.33)
Weighted Average Diluted Shares Outstanding	51.31M	47.18M	44.79M	25.78M	5.72M	5.49M
Weighted Average Basic & Diluted Shares Outstanding	53.10M	49.26M	45.61M	44.17M	-	-
Cash Dividends to Common per Share	$0.00	$0.00	$0.00	$0.00	$0.00	-

This table shows Couchbase's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-16	-18	-20	-21	-21	-16	-21	-22	-17	-17	-15
Consolidated Net Income / (Loss)	-16	-18	-20	-21	-21	-16	-21	-22	-17	-17	-15
Net Income / (Loss) Continuing Operations	-16	-18	-20	-21	-21	-16	-21	-22	-17	-17	-15
Total Pre-Tax Income	-15	-17	-19	-21	-21	-16	-21	-21	-17	-16	-15
Total Operating Income	-16	-19	-21	-23	-23	-18	-22	-23	-19	-17	-15
Total Gross Profit	49	45	45	46	45	41	37	35	36	34	35
Total Revenue	55	52	52	51	50	46	43	41	42	39	40
Operating Revenue	55	52	52	51	50	46	43	41	42	39	40
Total Cost of Revenue	6.26	6.56	6.46	5.68	5.14	5.11	5.91	5.92	5.95	4.88	4.78
Operating Cost of Revenue	6.26	6.56	6.46	5.68	5.14	5.11	5.91	5.92	5.95	4.88	4.78
Total Operating Expenses	64	64	66	68	68	58	59	58	54	50	50
Selling, General & Admin Expense	13	13	13	13	12	11	10	9.63	8.21	8.83	8.43
Marketing Expense	34	34	36	38	34	32	32	33	29	27	27
Research & Development Expense	18	17	17	18	16	16	16	15	15	14	14
Total Other Income / (Expense), net	0.79	1.77	1.71	1.53	1.77	1.30	1.24	1.41	1.91	0.29	0.24
Interest Expense	0.01	0.02	0.03	0.00	-	0.00	0.02	0.03	0.03	0.03	0.03
Other Income / (Expense), net	0.80	1.79	1.74	1.53	1.77	1.30	1.26	1.43	1.94	0.32	0.26
Income Tax Expense	0.55	0.69	0.56	0.00	0.61	0.00	0.00	0.75	0.03	0.38	0.37
Basic Earnings per Share	($0.29)	($0.35)	($0.39)	($0.42)	($0.44)	($0.34)	($0.44)	($0.48)	($0.37)	($0.37)	($0.34)
Weighted Average Basic Shares Outstanding	51.31M	51.83M	50.82M	49.79M	47.18M	47.59M	46.71M	45.84M	44.79M	44.93M	44.65M
Diluted Earnings per Share	($0.29)	($0.35)	($0.39)	($0.42)	($0.44)	($0.34)	($0.44)	($0.48)	($0.37)	($0.37)	($0.34)
Weighted Average Diluted Shares Outstanding	51.31M	51.83M	50.82M	49.79M	47.18M	47.59M	46.71M	45.84M	44.79M	44.93M	44.65M
Weighted Average Basic & Diluted Shares Outstanding	53.10M	52.35M	51.32M	50.31M	49.26M	48.07M	47.07M	46.41M	45.61M	45.17M	44.79M

This table details how cash moves in and out of Couchbase's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2025	2024	2023	2022	2021	2020
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020
Net Change in Cash & Equivalents	-11	0.91	-55	58	19	9.18
Net Cash From Operating Activities	-16	-27	-41	-42	-39	-22
Net Cash From Continuing Operating Activities	-16	-27	-41	-42	-39	-22
Net Income / (Loss) Continuing Operations	-75	-80	-68	-58	-40	-29
Consolidated Net Income / (Loss)	-75	-80	-68	-58	-40	-29
Depreciation Expense	2.28	2.42	3.17	2.82	2.01	0.71
Amortization Expense	15	15	17	14	11	7.99
Non-Cash Adjustments To Reconcile Net Income	66	55	29	11	4.87	3.73
Changes in Operating Assets and Liabilities, net	-24	-19	-22	-11	-17	-4.93
Net Cash From Investing Activities	-4.85	15	-23	-92	-22	-4.71
Net Cash From Continuing Investing Activities	-4.85	15	-23	-92	-22	-4.71
Purchase of Property, Plant & Equipment	-3.02	-4.71	-5.65	-0.82	-2.82	-4.71
Purchase of Investments	-101	-131	-145	-112	-20	0.00
Sale and/or Maturity of Investments	99	151	127	21	0.90	0.00
Net Cash From Financing Activities	9.94	13	9.71	192	81	36
Net Cash From Continuing Financing Activities	9.94	13	9.71	192	81	36
Issuance of Common Equity	3.52	2.00	4.48	215	0.00	0.00
Other Financing Activities, net	6.42	11	5.22	7.49	2.19	0.98
Effect of Exchange Rate Changes	-0.62	-0.56	-0.40	-0.42	0.16	-0.14
Cash Interest Paid	0.05	0.04	0.10	0.62	5.95	3.85
Cash Income Taxes Paid	1.77	2.47	0.78	0.80	0.87	0.51

This table details how cash moves in and out of Couchbase's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Change in Cash & Equivalents	-2.50	-30	11	10	-5.56	5.47	-4.80	5.79	1.67	-7.56	-1.33
Net Cash From Operating Activities	4.36	-17	-4.85	1.56	-6.45	-13	-0.52	-7.18	-10	-15	-7.66
Net Cash From Continuing Operating Activities	4.36	-17	-4.85	1.56	-6.45	-13	-0.52	-7.18	-10	-15	-7.66
Net Income / (Loss) Continuing Operations	-16	-18	-20	-21	-21	-16	-21	-22	-17	-17	-15
Consolidated Net Income / (Loss)	-16	-18	-20	-21	-21	-16	-21	-22	-17	-17	-15
Depreciation Expense	0.76	0.76	0.36	0.40	0.39	0.40	0.75	0.89	0.87	0.84	0.73
Amortization Expense	2.33	4.38	4.18	4.10	1.19	4.50	4.70	4.54	3.97	4.14	4.40
Non-Cash Adjustments To Reconcile Net Income	19	16	16	15	21	12	12	9.22	6.73	7.64	7.64
Changes in Operating Assets and Liabilities, net	-1.96	-20	-5.84	3.21	-8.01	-14	2.57	0.05	-5.15	-11	-5.06
Net Cash From Investing Activities	-7.74	-15	15	3.70	-2.67	15	-6.87	10	10	5.56	5.69
Net Cash From Continuing Investing Activities	-7.74	-15	15	3.70	-2.67	15	-6.87	10	10	5.56	5.69
Purchase of Property, Plant & Equipment	-0.38	-0.58	-1.07	-1.00	-1.29	-1.07	-1.07	-1.29	-1.55	-1.62	-1.68
Purchase of Investments	-25	-38	-18	-19	-41	-26	-56	-7.82	-34	-41	-16
Sale and/or Maturity of Investments	18	23	34	24	39	42	51	19	46	48	23
Net Cash From Financing Activities	1.17	2.84	0.84	5.09	3.58	3.86	2.73	2.76	1.19	1.63	0.75
Net Cash From Continuing Financing Activities	1.17	2.84	0.84	5.09	3.58	3.86	2.73	2.76	1.19	1.63	0.75
Other Financing Activities, net	1.17	1.12	0.84	3.29	3.58	2.70	2.73	1.92	1.19	0.67	0.75
Effect of Exchange Rate Changes	-0.29	-0.12	0.06	-0.26	-0.02	-0.29	-0.15	-0.10	0.46	-0.02	-0.12
Cash Interest Paid	0.02	0.02	0.01	0.00	-	-	0.02	0.03	0.03	0.03	0.03
Cash Income Taxes Paid	0.34	0.29	0.55	0.59	1.22	0.84	0.12	0.29	0.16	0.26	0.08

This table presents Couchbase's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2025	2024	2023	2022	2021
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021
Total Assets	261	248	253	277	117
Total Current Assets	228	224	229	263	104
Cash & Equivalents	31	41	40	96	37
Short-Term Investments	117	112	128	110	20
Accounts Receivable	49	45	40	37	36
Prepaid Expenses	15	10	8.23	8.56	2.45
Other Current Assets	17	15	13	12	8.35
Plant, Property, & Equipment, net	7.21	5.33	7.43	4.29	6.51
Total Noncurrent Assets	25	18	16	9.46	7.14
Other Noncurrent Operating Assets	25	18	16	9.46	7.14
Total Liabilities & Shareholders' Equity	261	248	253	277	117
Total Liabilities	133	117	103	94	104
Total Current Liabilities	127	113	95	90	73
Accounts Payable	2.19	4.87	1.41	1.92	2.43
Accrued Expenses	8.44	4.58	6.08	3.23	4.15
Current Deferred Revenue	94	82	72	69	57
Current Employee Benefit Liabilities	21	18	13	16	9.11
Other Current Liabilities	1.36	3.21	3.12	0.00	-
Total Noncurrent Liabilities	5.65	4.83	7.82	3.22	31
Noncurrent Deferred Revenue	2.69	2.75	3.28	2.71	4.54
Other Noncurrent Operating Liabilities	2.96	2.08	4.54	0.51	1.36
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	128	130	150	183	-246
Total Preferred & Common Equity	128	130	150	183	-246
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	128	130	150	183	-246
Common Stock	693	621	562	525	37
Retained Earnings	-565	-491	-410	-342	-284
Accumulated Other Comprehensive Income / (Loss)	0.12	0.06	-0.81	-0.20	0.00

This table presents Couchbase's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	10/31/2024	7/31/2024	4/30/2024	10/31/2023	7/31/2023	4/30/2023	10/31/2022	7/31/2022	4/30/2022	10/31/2021
Total Assets	222	236	243	232	244	249	242	265	267	260
Total Current Assets	194	211	218	207	219	226	220	242	245	248
Cash & Equivalents	33	63	52	47	41	46	39	46	48	141
Short-Term Investments	109	94	108	110	124	117	138	146	153	66
Accounts Receivable	29	31	35	30	32	42	23	29	25	23
Prepaid Expenses	11	10	10	7.45	8.03	6.84	7.77	9.66	8.01	8.19
Other Current Assets	13	13	13	13	13	13	12	12	12	9.22
Plant, Property, & Equipment, net	7.00	7.05	6.11	9.63	8.58	8.03	6.73	5.64	4.34	4.98
Total Noncurrent Assets	21	18	18	15	16	16	16	17	17	7.14
Other Noncurrent Operating Assets	21	18	18	15	16	16	16	17	17	7.14
Total Liabilities & Shareholders' Equity	222	236	243	232	244	249	242	265	267	260
Total Liabilities	96	109	114	97	108	109	84	98	93	68
Total Current Liabilities	91	107	110	90	102	102	77	90	85	64
Accounts Payable	4.72	5.03	4.07	3.17	3.16	6.87	3.52	5.58	2.64	3.52
Accrued Expenses	3.98	3.37	3.81	3.40	4.87	4.81	3.31	4.10	2.95	2.53
Current Deferred Revenue	68	82	90	72	80	79	58	67	68	48
Current Employee Benefit Liabilities	12	14	8.94	9.12	11	8.50	9.05	11	8.03	-
Other Current Liabilities	2.15	2.67	3.11	2.98	2.98	3.06	3.04	3.08	2.72	-
Total Noncurrent Liabilities	4.51	2.20	3.96	6.52	6.49	6.75	7.24	7.96	7.92	4.02
Noncurrent Deferred Revenue	0.83	1.03	2.57	3.78	3.22	2.87	2.58	2.47	2.29	2.73
Other Noncurrent Operating Liabilities	3.68	1.17	1.39	2.74	3.27	3.87	4.66	5.49	5.63	1.30
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	127	127	129	135	136	141	158	166	174	191
Total Preferred & Common Equity	127	127	129	135	136	141	158	166	174	191
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	127	127	129	135	136	141	158	166	174	191
Common Stock	676	658	641	605	589	574	553	545	537	520
Retained Earnings	-550	-532	-512	-469	-453	-432	-394	-377	-362	-329
Accumulated Other Comprehensive Income / (Loss)	0.12	0.03	-0.22	-0.11	-0.30	-0.49	-1.38	-1.04	-0.88	-0.03

This table displays calculated financial ratios and metrics derived from Couchbase's official financial filings.

Metric	2025	2024	2023	2022	2021	2020
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020
Growth Metrics	-	-	-	-	-	-
Revenue Growth	16.35%	16.28%	25.32%	19.61%	25.16%	0.00%
EBITDA Growth	9.61%	-28.87%	-19.42%	-111.84%	-24.55%	0.00%
EBIT Growth	7.61%	-16.97%	-19.09%	-76.92%	-34.13%	0.00%
NOPAT Growth	6.96%	-21.96%	-23.21%	-70.07%	-9.02%	0.00%
Net Income Growth	6.90%	-17.07%	-17.63%	-45.63%	-36.66%	0.00%
EPS Growth	14.71%	-11.11%	35.44%	69.26%	-44.65%	0.00%
Operating Cash Flow Growth	41.14%	34.70%	0.94%	-6.12%	-80.07%	0.00%
Free Cash Flow Firm Growth	-8.72%	-1.47%	-51.82%	-639.43%	0.00%	0.00%
Invested Capital Growth	15.75%	-28.68%	20.67%	-23.48%	0.00%	0.00%
Revenue Q/Q Growth	2.36%	4.93%	4.42%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	6.10%	-14.97%	-7.82%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	7.38%	-5.72%	-5.71%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	7.91%	-5.09%	-9.19%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	7.20%	-6.35%	-5.19%	0.00%	0.00%	0.00%
EPS Q/Q Growth	9.38%	-4.29%	-233.04%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	40.58%	12.25%	-22.45%	8.61%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	11.02%	0.19%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-28.98%	-8.68%	5.81%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	88.08%	87.73%	86.91%	88.04%	88.75%	90.55%
EBITDA Margin	-26.51%	-34.12%	-30.79%	-32.31%	-18.24%	-18.33%
Operating Margin	-37.55%	-46.96%	-44.77%	-45.54%	-32.03%	-36.77%
EBIT Margin	-34.75%	-43.76%	-43.50%	-45.78%	-30.95%	-28.88%
Profit (Net Income) Margin	-35.64%	-44.54%	-44.24%	-47.13%	-38.71%	-35.45%
Tax Burden Percent	102.47%	101.72%	101.54%	101.77%	102.68%	102.69%
Interest Burden Percent	100.08%	100.05%	100.15%	101.16%	121.80%	119.54%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-57.86%	-57.13%	-41.08%	-59.21%	-296.61%	0.00%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-28.64%	-31.46%	-25.43%	-28.71%	-27.28%	0.00%
Return on Assets (ROA)	-29.37%	-32.02%	-25.86%	-29.56%	-34.12%	0.00%
Return on Common Equity (ROCE)	-57.86%	-57.13%	-41.08%	19.00%	5,420.43%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-58.50%	-61.48%	-45.58%	-31.78%	16.23%	0.00%
Net Operating Profit after Tax (NOPAT)	-55	-59	-49	-39	-23	-21
NOPAT Margin	-26.29%	-32.87%	-31.34%	-31.88%	-22.42%	-25.74%
Net Nonoperating Expense Percent (NNEP)	-13.03%	-13.05%	-10.67%	-15.85%	-105.52%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-43.14%	-45.37%	-32.29%	-	-	-
Cost of Revenue to Revenue	11.92%	12.27%	13.09%	11.96%	11.25%	9.45%
SG&A Expenses to Revenue	24.18%	23.70%	21.57%	19.43%	15.01%	18.86%
R&D to Revenue	33.69%	35.59%	37.31%	41.80%	37.76%	38.38%
Operating Expenses to Revenue	125.63%	134.69%	131.69%	133.57%	120.78%	127.32%
Earnings before Interest and Taxes (EBIT)	-73	-79	-67	-57	-32	-24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-56	-61	-48	-40	-19	-15
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	7.28	9.21	4.45	5.58	0.00	0.00
Price to Tangible Book Value (P/TBV)	7.28	9.21	4.45	5.58	0.00	0.00
Price to Revenue (P/Rev)	4.43	6.68	4.32	8.27	1.63	2.04
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	3.73	5.82	3.23	6.60	3.83	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	1.85	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	1.85	0.00
Financial Leverage	-1.17	-1.15	-1.12	-1.21	-2.37	0.00
Leverage Ratio	1.97	1.78	1.59	2.00	8.69	0.00
Compound Leverage Factor	1.97	1.79	1.59	2.03	10.59	0.00
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	64.92%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	64.92%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	676.13%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	-641.05%	0.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	-1.32	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	1.69	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	-1.32	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	-1.08	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	1.38	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	-1.08	0.00
Altman Z-Score	1.50	3.59	2.00	5.34	-2.12	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	132.09%	1,927.46%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	1.79	1.99	2.42	2.91	1.42	0.00
Quick Ratio	1.54	1.76	2.19	2.69	1.27	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-59	-54	-53	-35	-4.74	0.00
Operating Cash Flow to CapEx	-524.11%	-570.98%	-729.45%	-5,076.19%	-1,389.78%	-461.93%
Free Cash Flow to Firm to Interest Expense	-978.58	-1,255.88	-526.95	-53.44	-0.68	0.00
Operating Cash Flow to Interest Expense	-263.80	-625.42	-407.77	-63.38	-5.62	-4.67
Operating Cash Flow Less CapEx to Interest Expense	-314.13	-734.95	-463.67	-64.62	-6.03	-5.68
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.82	0.72	0.58	0.63	0.88	0.00
Accounts Receivable Turnover	4.45	4.25	4.05	3.40	2.88	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	33.41	28.23	26.43	22.89	15.88	0.00
Accounts Payable Turnover	7.08	7.04	12.17	6.79	4.78	0.00
Days Sales Outstanding (DSO)	81.98	85.85	90.23	107.24	126.86	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	51.56	51.84	30.00	53.72	76.29	0.00
Cash Conversion Cycle (CCC)	30.42	34.02	60.23	53.52	50.57	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	-20	-23	-18	-23	-18	0.00
Invested Capital Turnover	-9.80	-8.73	-7.59	-6.00	-11.22	0.00
Increase / (Decrease) in Invested Capital	3.66	-5.17	4.70	-4.32	-18	0.00
Enterprise Value (EV)	781	1,048	500	815	396	0.00
Market Capitalization	929	1,202	668	1,021	168	168
Book Value per Share	$2.44	$2.71	$3.33	$4.20	($43.09)	$0.00
Tangible Book Value per Share	$2.44	$2.71	$3.33	$4.20	($43.09)	$0.00
Total Capital	128	130	150	183	38	0.00
Total Debt	0.00	0.00	0.00	0.00	25	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	25	0.00
Net Debt	-147	-154	-168	-206	-32	0.00
Capital Expenditures (CapEx)	3.02	4.71	5.65	0.82	2.82	4.71
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-46	-42	-34	-33	-26	0.00
Debt-free Net Working Capital (DFNWC)	101	112	135	173	31	0.00
Net Working Capital (NWC)	101	112	135	173	31	0.00
Net Nonoperating Expense (NNE)	20	21	20	19	17	8.02
Net Nonoperating Obligations (NNO)	-147	-154	-168	-206	-32	0.00
Total Depreciation and Amortization (D&A)	17	17	20	17	13	8.70
Debt-free, Cash-free Net Working Capital to Revenue	-22.01%	-23.25%	-21.82%	-26.93%	-25.33%	0.00%
Debt-free Net Working Capital to Revenue	48.25%	62.09%	86.89%	139.78%	29.71%	0.00%
Net Working Capital to Revenue	48.25%	62.09%	86.89%	139.78%	29.71%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.45)	($1.70)	($1.53)	($2.37)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	51.31M	47.18M	44.79M	25.78M	0.00	0.00
Adjusted Diluted Earnings per Share	($1.45)	($1.70)	($1.53)	($2.37)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	51.31M	47.18M	44.79M	25.78M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.10M	49.26M	45.61M	44.17M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-55	-56	-47	-39	-23	-21
Normalized NOPAT Margin	-26.29%	-30.85%	-30.59%	-31.88%	-22.42%	-25.74%
Pre Tax Income Margin	-34.78%	-43.78%	-43.57%	-46.31%	-37.70%	-34.53%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-1,213.18	-1,832.21	-666.88	-86.22	-4.59	-5.12
NOPAT to Interest Expense	-917.64	-1,376.18	-480.40	-60.03	-3.32	-4.56
EBIT Less CapEx to Interest Expense	-1,263.52	-1,941.74	-722.78	-87.46	-4.99	-6.13
NOPAT Less CapEx to Interest Expense	-967.98	-1,485.72	-536.30	-61.28	-3.73	-5.57
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	-8.47%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Couchbase's official financial filings.

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.65%	12.69%	19.59%	25.20%	20.34%	18.82%	8.41%	17.63%	18.71%	25.09%	33.98%
EBITDA Growth	37.94%	-8.52%	2.68%	-5.38%	-64.07%	-0.42%	-54.07%	-5.91%	-41.79%	0.02%	1.42%
EBIT Growth	27.83%	-7.39%	6.34%	0.43%	-25.74%	0.19%	-37.68%	-7.96%	-28.16%	-4.72%	-6.43%
NOPAT Growth	29.92%	-9.65%	3.75%	-0.03%	-22.11%	-5.73%	-43.56%	-18.67%	-46.05%	-7.11%	-8.88%
Net Income Growth	27.06%	-11.67%	3.66%	4.02%	-28.82%	2.53%	-34.37%	-10.29%	-25.52%	-4.73%	-6.21%
EPS Growth	34.09%	-2.94%	11.36%	12.50%	-18.92%	8.11%	-29.41%	-6.67%	-116.02%	0.00%	80.68%
Operating Cash Flow Growth	167.57%	-32.58%	-834.49%	121.71%	36.78%	13.43%	93.22%	16.57%	-284.73%	25.46%	52.11%
Free Cash Flow Firm Growth	-38.50%	-95.19%	-43.90%	63.08%	39.71%	-877.43%	3.18%	-247.18%	0.00%	128.15%	-167.89%
Invested Capital Growth	15.75%	29.01%	2.53%	-37.19%	-28.68%	-11.52%	-17.64%	15.32%	20.67%	-206.86%	1.76%
Revenue Q/Q Growth	6.38%	0.08%	0.51%	2.47%	9.33%	6.20%	5.23%	-1.51%	7.95%	-3.10%	14.17%
EBITDA Q/Q Growth	2.98%	16.59%	10.62%	-6.19%	-69.67%	25.20%	3.21%	-39.29%	-3.84%	-14.77%	33.47%
EBIT Q/Q Growth	13.83%	9.65%	8.10%	-0.87%	-28.21%	21.20%	2.30%	-27.38%	-1.78%	-8.70%	23.39%
NOPAT Q/Q Growth	17.68%	8.62%	6.62%	0.23%	-28.79%	19.79%	2.95%	-21.79%	-11.51%	-8.92%	19.78%
Net Income Q/Q Growth	14.00%	8.76%	5.24%	1.90%	-31.66%	21.29%	5.60%	-31.67%	0.38%	-8.51%	22.51%
EPS Q/Q Growth	17.14%	10.26%	7.14%	4.55%	-29.41%	22.73%	8.33%	-29.73%	0.00%	-8.82%	24.44%
Operating Cash Flow Q/Q Growth	125.79%	-248.35%	-411.10%	124.17%	49.38%	-2,355.30%	92.77%	29.62%	30.69%	-92.29%	11.06%
Free Cash Flow Firm Q/Q Growth	25.03%	-26.85%	-111.22%	31.05%	-5.66%	6.49%	45.81%	-12.60%	-1,462.49%	111.65%	-182.38%
Invested Capital Q/Q Growth	-28.98%	48.59%	5.28%	-34.13%	-8.68%	29.41%	-33.33%	-25.81%	5.81%	25.54%	4.02%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	88.61%	87.30%	87.47%	88.93%	89.74%	88.84%	86.30%	85.55%	85.70%	87.36%	87.98%
EBITDA Margin	-21.75%	-23.85%	-28.61%	-32.17%	-38.43%	-24.76%	-35.16%	-38.22%	-28.19%	-29.30%	-24.74%
Operating Margin	-28.83%	-37.26%	-40.80%	-43.91%	-45.11%	-38.29%	-50.69%	-54.96%	-44.45%	-43.03%	-38.28%
EBIT Margin	-27.37%	-33.79%	-37.42%	-40.93%	-41.58%	-35.46%	-47.79%	-51.47%	-39.80%	-42.21%	-37.63%
Profit (Net Income) Margin	-28.42%	-35.16%	-38.56%	-40.90%	-42.73%	-35.48%	-47.87%	-53.36%	-39.92%	-43.25%	-38.62%
Tax Burden Percent	103.76%	103.96%	102.89%	99.93%	102.76%	100.07%	100.09%	103.55%	100.15%	102.31%	102.48%
Interest Burden Percent	100.09%	100.10%	100.15%	100.00%	100.00%	100.00%	100.09%	100.12%	100.15%	100.16%	100.17%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-57.86%	-61.40%	-59.92%	-58.74%	-57.13%	-51.40%	-50.22%	-44.75%	-41.08%	-37.26%	-34.90%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-22.55%	-30.43%	-31.03%	-31.67%	-29.90%	-25.65%	-30.89%	-32.08%	-23.26%	-24.93%	-18.63%
Return on Assets (ROA)	-23.42%	-31.66%	-31.97%	-31.65%	-30.72%	-25.67%	-30.94%	-33.26%	-23.33%	-25.55%	-19.13%
Return on Common Equity (ROCE)	-57.86%	-61.40%	-59.92%	-58.74%	-57.13%	-51.40%	-50.22%	-44.75%	-41.08%	-37.26%	-34.90%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-63.45%	-62.02%	-61.45%	0.00%	-55.74%	-55.94%	-50.04%	0.00%	-41.19%	-38.68%
Net Operating Profit after Tax (NOPAT)	-11	-13	-15	-16	-16	-12	-15	-16	-13	-12	-11
NOPAT Margin	-20.18%	-26.08%	-28.56%	-30.74%	-31.57%	-26.80%	-35.49%	-38.47%	-31.12%	-30.12%	-26.80%
Net Nonoperating Expense Percent (NNEP)	-3.01%	-3.14%	-3.21%	-3.22%	-3.47%	-2.38%	-2.99%	-3.35%	-1.96%	-2.70%	-2.24%
Return On Investment Capital (ROIC_SIMPLE)	-8.68%	-	-	-	-12.13%	-	-	-	-8.62%	-	-
Cost of Revenue to Revenue	11.39%	12.70%	12.53%	11.07%	10.26%	11.16%	13.70%	14.45%	14.30%	12.64%	12.02%
SG&A Expenses to Revenue	23.32%	24.45%	24.49%	24.52%	23.64%	23.44%	24.24%	23.48%	19.72%	22.90%	21.18%
R&D to Revenue	32.54%	33.87%	33.67%	34.77%	32.92%	34.71%	37.77%	37.52%	36.04%	36.30%	36.04%
Operating Expenses to Revenue	117.43%	124.56%	128.27%	132.84%	134.84%	127.13%	137.00%	140.52%	130.15%	130.39%	126.27%
Earnings before Interest and Taxes (EBIT)	-15	-17	-19	-21	-21	-16	-21	-21	-17	-16	-15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-12	-12	-15	-17	-19	-11	-15	-16	-12	-11	-9.84
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.28	6.51	7.62	9.21	9.21	5.42	5.71	4.97	4.45	3.63	4.08
Price to Tangible Book Value (P/TBV)	7.28	6.51	7.62	9.21	9.21	5.42	5.71	4.97	4.45	3.63	4.08
Price to Revenue (P/Rev)	4.43	4.03	4.86	6.25	6.68	4.27	4.71	4.35	4.32	3.87	4.83
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	3.73	3.34	4.07	5.41	5.82	3.36	3.70	3.34	3.23	2.67	3.46
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.17	-1.14	-1.23	-1.20	-1.15	-1.14	-1.19	-1.16	-1.12	-1.07	-1.14
Leverage Ratio	1.97	1.73	1.83	1.82	1.78	1.62	1.68	1.64	1.59	1.44	1.54
Compound Leverage Factor	1.97	1.74	1.83	1.82	1.78	1.62	1.69	1.64	1.59	1.44	1.54
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	2.23	2.93	3.25	4.37	4.36	2.83	2.67	2.41	2.66	2.91	3.18
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.79	2.13	1.97	1.99	1.99	2.30	2.16	2.22	2.42	2.85	2.68
Quick Ratio	1.54	1.87	1.75	1.78	1.76	2.07	1.95	2.02	2.19	2.60	2.45
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-15	-20	-15	-7.34	-11	-10	-11	-20	-18	1.30	-11
Operating Cash Flow to CapEx	1,162.13%	-2,897.94%	-454.55%	156.68%	-501.95%	-1,195.40%	-48.46%	-557.53%	-656.99%	-910.33%	-456.47%
Free Cash Flow to Firm to Interest Expense	-1,052.79	-1,156.52	-534.47	0.00	0.00	0.00	-598.41	-795.08	-706.10	49.83	-445.00
Operating Cash Flow to Interest Expense	311.29	-993.82	-167.24	0.00	0.00	0.00	-28.83	-287.24	-408.12	-566.15	-306.20
Operating Cash Flow Less CapEx to Interest Expense	284.50	-1,028.12	-204.03	0.00	0.00	0.00	-88.33	-338.76	-470.24	-628.35	-373.28
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.82	0.90	0.83	0.77	0.72	0.72	0.65	0.62	0.58	0.59	0.50
Accounts Receivable Turnover	4.45	6.94	6.24	4.96	4.25	6.47	5.35	4.82	4.05	6.58	5.71
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	33.41	24.61	25.43	26.92	28.23	20.97	23.11	26.02	26.43	25.31	25.06
Accounts Payable Turnover	7.08	6.04	5.47	3.99	7.04	6.84	5.19	4.53	12.17	5.24	2.72
Days Sales Outstanding (DSO)	81.98	52.63	58.49	73.62	85.85	56.40	68.27	75.77	90.23	55.46	63.89
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	51.56	60.44	66.71	91.38	51.84	53.37	70.36	80.57	30.00	69.70	134.34
Cash Conversion Cycle (CCC)	30.42	-7.82	-8.23	-17.76	34.02	3.03	-2.08	-4.80	60.23	-14.25	-70.45
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-20	-15	-29	-31	-23	-21	-30	-23	-18	-19	-26
Invested Capital Turnover	-9.80	-11.21	-6.66	-7.07	-8.73	-8.47	-5.87	-6.51	-7.59	-11.68	-5.42
Increase / (Decrease) in Invested Capital	3.66	6.20	0.77	-8.44	-5.17	-2.21	-4.54	4.10	4.70	-13	0.46
Enterprise Value (EV)	781	683	809	1,029	1,048	576	609	537	500	396	486
Market Capitalization	929	825	965	1,189	1,202	732	775	701	668	573	679
Book Value per Share	$2.44	$2.47	$2.52	$2.62	$2.71	$2.87	$2.92	$3.09	$3.33	$3.53	$3.73
Tangible Book Value per Share	$2.44	$2.47	$2.52	$2.62	$2.71	$2.87	$2.92	$3.09	$3.33	$3.53	$3.73
Total Capital	128	127	127	129	130	135	136	141	150	158	166
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-147	-142	-156	-160	-154	-157	-166	-164	-168	-177	-192
Capital Expenditures (CapEx)	0.38	0.58	1.07	1.00	1.29	1.07	1.07	1.29	1.55	1.62	1.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-46	-39	-53	-51	-42	-39	-48	-40	-34	-35	-40
Debt-free Net Working Capital (DFNWC)	101	103	104	109	112	117	117	124	135	143	152
Net Working Capital (NWC)	101	103	104	109	112	117	117	124	135	143	152
Net Nonoperating Expense (NNE)	4.53	4.69	5.16	5.22	5.59	3.98	5.34	6.10	3.66	5.06	4.71
Net Nonoperating Obligations (NNO)	-147	-142	-156	-160	-154	-157	-166	-164	-168	-177	-192
Total Depreciation and Amortization (D&A)	3.09	5.13	4.55	4.50	1.58	4.90	5.45	5.43	4.83	4.98	5.13
Debt-free, Cash-free Net Working Capital to Revenue	-22.01%	-18.97%	-26.44%	-27.02%	-23.25%	-22.96%	-29.42%	-24.79%	-21.82%	-23.27%	-28.63%
Debt-free Net Working Capital to Revenue	48.25%	50.40%	52.09%	57.13%	62.09%	68.33%	71.48%	76.87%	86.89%	96.28%	108.07%
Net Working Capital to Revenue	48.25%	50.40%	52.09%	57.13%	62.09%	68.33%	71.48%	76.87%	86.89%	96.28%	108.07%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.29)	($0.35)	($0.39)	($0.42)	($0.44)	($0.34)	($0.44)	($0.48)	($0.37)	($0.37)	($0.34)
Adjusted Weighted Average Basic Shares Outstanding	51.31M	51.83M	50.82M	49.79M	47.18M	47.59M	46.71M	45.84M	44.79M	44.93M	44.65M
Adjusted Diluted Earnings per Share	($0.29)	($0.35)	($0.39)	($0.42)	($0.44)	($0.34)	($0.44)	($0.48)	($0.37)	($0.37)	($0.34)
Adjusted Weighted Average Diluted Shares Outstanding	51.31M	51.83M	50.82M	49.79M	47.18M	47.59M	46.71M	45.84M	44.79M	44.93M	44.65M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.10M	52.35M	51.32M	50.31M	49.26M	48.07M	47.07M	46.41M	45.61M	45.17M	44.79M
Normalized Net Operating Profit after Tax (NOPAT)	-11	-13	-15	-16	-16	-12	-15	-16	-12	-12	-11
Normalized NOPAT Margin	-20.18%	-26.08%	-28.56%	-30.74%	-31.57%	-26.80%	-35.49%	-38.40%	-28.32%	-30.12%	-26.80%
Pre Tax Income Margin	-27.39%	-33.82%	-37.48%	-40.93%	-41.58%	-35.46%	-47.83%	-51.53%	-39.86%	-42.28%	-37.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-1,073.64	-1,026.12	-665.76	0.00	0.00	0.00	-1,145.22	-844.00	-662.56	-625.96	-598.88
NOPAT to Interest Expense	-791.65	-791.99	-508.06	0.00	0.00	0.00	-850.46	-630.92	-518.06	-446.71	-426.52
EBIT Less CapEx to Interest Expense	-1,100.43	-1,060.41	-702.55	0.00	0.00	0.00	-1,204.72	-895.52	-724.68	-688.15	-665.96
NOPAT Less CapEx to Interest Expense	-818.44	-826.28	-544.85	0.00	0.00	0.00	-909.96	-682.44	-580.18	-508.90	-493.60
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Couchbase's Financials

When does Couchbase's financial year end?

According to the most recent income statement we have on file, Couchbase's fiscal year ends in January. Their fiscal year 2025 ended on January 31, 2025.

How has Couchbase's net income changed over the last 5 years?

Couchbase's net income appears to be on an upward trend, with a most recent value of -$74.65 million in 2025, rising from -$29.26 million in 2020. The previous period was -$80.18 million in 2024. Check out Couchbase's forecast to explore projected trends and price targets.

What is Couchbase's operating income?

Couchbase's total operating income in 2025 was -$78.66 million, based on the following breakdown:

Total Gross Profit: $184.51 million
Total Operating Expenses: $263.16 million

How has Couchbase revenue changed over the last 5 years?

Over the last 5 years, Couchbase's total revenue changed from $82.52 million in 2020 to $209.47 million in 2025, a change of 153.8%.

How much debt does Couchbase have?

Couchbase's total liabilities were at $132.98 million at the end of 2025, a 13.3% increase from 2024, and a 28.2% increase since 2021.

How much cash does Couchbase have?

In the past 4 years, Couchbase's cash and equivalents has ranged from $30.54 million in 2025 to $95.69 million in 2022, and is currently $30.54 million as of their latest financial filing in 2025.

How has Couchbase's book value per share changed over the last 5 years?

Over the last 5 years, Couchbase's book value per share changed from 0.00 in 2020 to 2.44 in 2025, a change of 243.8%.

Related Companies

This page (NASDAQ:BASE) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Couchbase (BASE) Financials

Frequently Asked Questions About Couchbase's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Couchbase (BASE) Financials

Annual Income Statements for Couchbase

Quarterly Income Statements for Couchbase

Annual Cash Flow Statements for Couchbase

Quarterly Cash Flow Statements for Couchbase

Annual Balance Sheets for Couchbase

Quarterly Balance Sheets for Couchbase

Annual Metrics And Ratios for Couchbase

Quarterly Metrics And Ratios for Couchbase

Frequently Asked Questions About Couchbase's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools